NT Pharma

Company Deals

China NT Pharma Group Enters MOU with Global Fund to Expand Orthopedic Product Line

Fineline Cube Oct 10, 2023

China NT Pharma Group Company Ltd (HKG: 1011), a China-based pharmaceutical company, has announced the...

Company Deals

China NT Pharma Group Inks Licensing Deal for Orticumab in Asia

Fineline Cube Jun 22, 2022

China-based China NT Pharma Group Company Ltd (HKG: 1011) has announced a licensing agreement with...

Company Deals

China NT Pharma Group Company Ltd Inks Licensing Deal for Monoclonal Antibodies

Fineline Cube Jun 15, 2022

China-based China NT Pharma Group Company Ltd (HKG: 1011) has announced a potential acquisition agreement...

Company Deals

AstraZeneca Secures Full Global Rights to AbelZeta’s C‑CAR031 in $630M CAR‑T Deal

Company Drug

Novartis’s Ianalumab Wins FDA Breakthrough Therapy Designation for Sjögren’s Disease

Company Deals

Medtronic and Precision Neuroscience Form First Brain‑Device Alliance to Access Neural Data

Company Drug

Akeso’s Gumokimab NMPA Filing for Ankylosing Spondylitis Expands IL‑17A Franchise